SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Insmed Inc. (INSM)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
136 17 0 INSM
Emcee:  SI (no user) Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
86Insmed Initiates Phase I Clinical Study for Novel Anti-Tumor 2004-09-08 16:30 (Nmopgcw-9/9/2004
85Insmed Requests Halt of Trading of Its Common Stock on the Berlin-Bremen Stock Emopgcw-8/17/2004
84CROOKE GRAHAM K,Director,BUYS 5,000 ON 8/4/04 OF INSM 2004-08-06 11:57 (New Yorkmopgcw-8/12/2004
83Insmed Incorporated Reports Financial Results for Second Quarter and First Half mopgcw-7/28/2004
82Insmed Reports Update on Pivotal Clinical Trial with 2004-07-20 16:05 (New York)mopgcw-7/21/2004
81Insmed Announces Two Independent Presentations at the National Cancer Institutesmopgcw-7/19/2004
80Insmed Receives Authorization for Reimbursement for SomatoKine 2004-07-12 19:14 mopgcw-7/12/2004
79From Yahoo: Biotech Insight by: rstor1 (44/M/NY) 06/25/04 07:39 am Msg: 19392 mopgcw-6/25/2004
78Insmed Incorporated Reports Financial Results for First Quarter of 2004 Wednesdamopgcw-5/6/2004
77positive news: "Insmed Acquires Manufacturing Facility from Baxter Internatom r. phillips-4/15/2004
76Insmed to Present Cancer Data On rhIGFBP-3 In Herceptin-Resistant Breast Tumors mopgcw-3/29/2004
75Insmed Incorporated Reports Improved Financial Results for Fourth Quarter 2003 amopgcw-2/25/2004
74BVF is reducing its stake in INSM down to about 2 million shares currentlymopgcw-2/5/2004
73University of Rochester Awarded $6.5 Million to Study Efficacy OF rhIGF-I/rhIGFBnigel bates-1/7/2004
72Continued slow cash in...CONDON KENNETH G,DIRECTOR,SELLS 34,000 ON 01/05/04 OF Imopgcw-1/6/2004
71INSM US: INSM Gets Orphan Drug Designation for SomatoKine 2003-12-15 13:47 (New mopgcw-12/16/2003
70Insmed Presents Positive Data on Anti-Cancer Drug Candidate to 2003-12-03 15:15 mopgcw-12/3/2003
69rhIGF-I/rhIGFBP-3, SomatoKine, Found to Delay the Onset of Type 2003-12-02 14:05mopgcw-12/2/2003
68Endocrinology. 2003 Nov 14 [Epub ahead of print]. Related Articles, Links Imopgcw-11/18/2003
67Insmed Presents Positive Data on Anti-Cancer Drug Candidate to AACR-NCI-EORTC Momopgcw-11/17/2003
66Note insiders have begun to steadily unload stock, albeit in small doses.mopgcw-10/22/2003
65Kevin McKenna, RBC Dain Rauscher Wessels - Analyst [2] ----------------------mopgcw-10/19/2003
64Final Event Transcript of INSM conference call, 31-Jul-03 11:00a 2003-08-01 11:5mopgcw-10/19/2003
63Competition: Message 19308434mopgcw-9/16/2003
62Insmed's Phase III Drug Candidate to Be Featured in Two Podium Presentationsmopgcw-9/15/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News